Patents by Inventor Sashank K. Reddy

Sashank K. Reddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYTOKINE COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20120269765
    Abstract: Polypeptides, including non-naturally occurring and recombinantly modified polypeptides related to the p19 subunit of IL-23, methods of making such molecules and methods of using such molecules as therapeutic, prophylactic and diagnostic agents are provided.
    Type: Application
    Filed: July 26, 2010
    Publication date: October 25, 2012
    Inventors: K. Christopher Garcia, Patrick Lupardus, Sashank K. Reddy, Gregory J. Sieczkiewicz
  • METHODS AND COMPOSITIONS FOR REDUCING STEMNESS IN ONCOGENESIS
    Publication number: 20110044895
    Abstract: The invention provides methods and compositions for reducing the number of cancer stem cells in a mixed population of differentiated cells (for example, cancer cells) and cancer stem cells. The cancer stem cells, if present, can be more resistant to traditional drug-based therapies and can provide a source for new, differentiated cancer cells associated with the development of drug-resistance and more aggressive phenotypes. When combined with traditional cancer therapies, for example, drug-based therapies, the methods and compositions of the invention provide a more effective way for treating cancer and can provide a model system for developing new cancer therapies and new treatment modalities.
    Type: Application
    Filed: August 9, 2010
    Publication date: February 24, 2011
    Inventors: David A. Berry, Eric J. Devroe, Noubar B. Afeyan, Brett Chevalier, Sashank K. Reddy
  • Methods and Compositions for Reducing Stemness in Oncogenesis
    Publication number: 20090047295
    Abstract: The invention provides methods and compositions for reducing the number of cancer stem cells in a mixed population of differentiated cells (for example, cancer cells) and cancer stem cells. The cancer stem cells, if present, can be more resistant to traditional drug-based therapies and can provide a source for new, differentiated cancer cells associated with the development of drug-resistance and more aggressive phenotypes. When combined with traditional cancer therapies, for example, drug-based therapies, the methods and compositions of the invention provide a more effective way for treating cancer and can provide a model system for developing new cancer therapies and new treatment modalities.
    Type: Application
    Filed: July 11, 2008
    Publication date: February 19, 2009
    Inventors: David A. Berry, Eric J. Devroe, Noubar Boghos Afeyan, Brett Chevalier, Sashank K. Reddy